• CLK2, BRCA1, and Platinum Resistance in Ovarian Cancer

  2026-08-13

  The reference study identifies CLK2 as a clinically relevant mediator of platinum resistance in ovarian cancer and connects its activity to BRCA1 Ser1423 phosphorylation and DNA damage repair. Its combination of patient-tissue analysis, cellular experiments, and xenograft validation provides a mechanistic framework for evaluating CLK2 as a therapeutic target, while also clarifying why kinase-selective pharmacology must be interpreted separately from genetic evidence.

• Hepatic sEH, Nrf2, and Osteoporosis

  2026-08-13

  The reference study identifies a liver–bone signaling axis in which hepatic soluble epoxide hydrolase promotes osteoclastogenesis by reducing circulating 14,15-EET and suppressing Nrf2-ARE antioxidant signaling. Its combination of patient samples, ovariectomy-induced osteoporosis, liver-specific knockdown, pharmacological inhibition, and transcriptomics provides a mechanistic framework for studying epoxyeicosatrienoic acids metabolism in bone loss.

• JZL184: From MAGL Biology to Translational Pain Strategy

  2026-08-13

  JZL184 offers a precise way to interrogate MAGL-dependent 2-AG turnover, CB1 signaling, synaptic plasticity, pain, and affective behavior. This thought-leadership guide connects molecular target engagement with translational study design while distinguishing established evidence from forward-looking hypotheses.

• Chloroquine in Cancer Therapy: Pharmacology and Prospects

  2026-08-12

  This 2024 review organizes the anticancer pharmacology of chloroquine around both autophagy-dependent and autophagy-independent mechanisms. Its practical value lies in linking lysosomal biology, cell-death signaling, combination therapy, toxicity, and translational limitations into a framework for designing better cancer studies.

• 4-Ethylphenyl Sulfate in Applied Research

  2026-08-12

  4-Ethylphenyl sulfate enables a practical bridge between renal toxin analytics, adsorption engineering, and gut microbiota-brain interaction research. This workflow-focused guide covers solution preparation, matrix testing, magnetic nano-adsorbent assays, neurobehavioral study design, and troubleshooting for reproducible results.

• Bobcat339 for TET and DNA Methylation Studies

  2026-08-11

  Bobcat339 provides a reversible, structure-based way to probe TET1/TET2 activity alongside DNA methylation, transcription, and osteogenic assays. This workflow connects compound treatment with the UHRF1–5-mC–super-enhancer–TGM2 axis described in senile osteoporosis research, while separating product-supported facts from experimental starting points.

• Palmitic acid: Practical Protocol & QC Guide

  2026-08-10

  Palmitic acid (SKU N2456) provides a characterized saturated long-chain fatty acid for in vitro studies of lipid metabolism, insulin signaling, inflammation signaling, and protein palmitoylation. It is intended for controlled solvent-based preparation, not aqueous dissolution or long-term storage of solutions.

• Laminin (925-933): Practical Assay Workflow

  2026-08-09

  Laminin (925-933) is a defined Laminin B1 chain peptide for controlled cell attachment, receptor-competition, and chemotaxis experiments. This article outlines preparation, assay controls, and troubleshooting; the peptide should not be treated as a substitute for full-length laminin or as a therapeutic metastasis inhibitor.

• Idoxuridine: Designing Causal Antiviral Assays

  2026-08-08

  Idoxuridine and 5-iodo-2'-deoxyuridine can do more than suppress viral growth endpoints: they can help researchers resolve how viral DNA synthesis fails. This article combines nucleoside-analog chemistry with a translational assay-design lesson from human sensory-neuron research.

• Curcumin, NLRP3, and Endothelial Pyroptosis

  2026-08-07

  Yuan et al. show that curcumin protects H2O2-injured human umbilical vein endothelial cells by suppressing NLRP3-associated pyroptosis and improving endothelial dysfunction markers. The study’s inhibitor-based design connects oxidative stress, inflammasome activation, and vascular injury while identifying important limits for translation beyond the HUVEC model.

• miR-196a Drives Esophageal Adenocarcinoma via c-Myc/TERT/NFκ

  2026-08-07

  This study reveals that microRNA-196a intensifies the aggressiveness of esophageal adenocarcinoma by activating the c-Myc/TERT/NFκB signaling cascade. These findings provide a mechanistic rationale for targeting c-Myc in cancer research and offer new directions for investigating molecular drivers of epithelial-to-mesenchymal transition and tumor progression.

• Finger Citron Mechanisms Against NAFLD: Network and Molecula

  2026-08-06

  This study integrates network pharmacology, molecular docking, and in vitro validation to reveal how bioactive compounds from finger citron, particularly 3,4,7-trimethoxycoumarin (TMC), target key pathways in non-alcoholic fatty liver disease (NAFLD). The findings highlight TMC’s modulation of lipid metabolism and inflammatory signaling, providing a mechanistic rationale for further research into finger citron as a potential NAFLD intervention.

• Lithium-Driven Osteogenesis via Exosomal Wnt10a and β-Cateni

  2026-08-06

  This study reveals that lithium enhances bone mesenchymal stem cell (BMSC) osteogenesis by stimulating exosomal Wnt10a secretion and activating β-catenin signaling. The mechanistic insights highlight Rab11a-dependent trafficking as a key regulator, offering new strategies for bone regeneration using engineered exosomes.

• nor-NOHA (acetate): Unlocking Arginase Inhibition for Immuno

  2026-08-05

  Explore the advanced role of nor-NOHA (acetate) in cancer research, focusing on its unique capacity for reversible arginase inhibition and its impact on immunometabolic pathways. This article reveals new experimental insights and practical protocol guidance, distinct from existing overviews.

• Primary Antibody Dilution Buffer: Precision in CNS Lymphoma

  2026-08-05

  The Primary Antibody Dilution Buffer from APExBIO advances immunohistochemistry by optimizing antibody specificity and penetration, a crucial advantage for research involving complex CNS tumor microenvironments. This guide translates cutting-edge findings into actionable protocols and troubleshooting strategies to elevate assay performance in challenging tissue contexts.

450 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page